The last small in number months of...

The last small in number months of 2004 were marked on crises likely to affect pharmaceutical and biotech manufacturing for years to result Safety data indicated that antidepressants may cause question s for young patients that warrant black coachman's seat warnings, new labeling, and special packaging. Merck plucked its blockbuster COX-2 inhibitor Vioxx not on the market because studies showed increased risk of cardiac facts from long-term use of the physic To cap it off, British regulators bar down Chiron's Liverpool vaccine plant appropriate to product contamination, creating a serious shortage of flu vaccine in the